
₹2,78,000(2,000 Shares)
Minimum Investment
IPO Dates
May 21, 2026 – May 25, 2026
Price Band
₹132–139 per equity share
Lot Size
1000
Listing
May 29, 2026
Listing At
NSE SME
NII Sub-Categories
sHNI (< ₹10L)
Bids ₹2L to ₹10L
bHNI (> ₹10L)
Bids above ₹10L
Overall Subscription
Total Bids Received
2.31x
Shares Offered
17,55,000
Shares Offered
36,000
Shares Offered
17,92,000
Shares Offered
1,89,000
The Bio Medica Laboratories deals in the manufacture of parenteral formulations that involve the development and supply of ethical drug products, generics, and over-the-counter drugs in liquid and dry...
EPS (Pre-IPO)
10.67
EPS (Post-IPO)
10.33
P/E (Pre-IPO)
13.03
P/E (Post-IPO)
13.45
RoNW
54.41%
PAT Margin
30.35%
P/B Value
8.66
Market Cap
₹174.79 Cr.
* All figures are in ₹ Crores unless otherwise stated.
Plot No. 11B-11C, Sector-E, Sanwer Road, Industrial Area, Industrial Estate (Indore), Indore, Madhya Pradesh - 452015.
Skyline Financial Services Private Ltd
The Bio Medica Laboratories Limited IPO price band is set at ₹132.00 to ₹139.00 per equity share.
The lot size for Bio Medica Laboratories Limited IPO is 1000 shares per lot. The minimum investment amount is approximately ₹1,39,000.
The Bio Medica Laboratories Limited IPO opens on May 21, 2026 and closes on May 25, 2026.
Bio Medica Laboratories Limited IPO is expected to be listed on May 29, 2026 on NSE SME.
The registrar for Bio Medica Laboratories Limited IPO is Skyline Financial Services Private Ltd. You can contact them at ipo@skylinerta.com.